Succinimide, N-methyl-2-phenyl-
Succinimide, N-methyl-2-phenyl- Brand names, Succinimide, N-methyl-2-phenyl- Analogs
- (+/-)-N-Methyl-2-phenylsuccinimide
- 1-Methyl-3-Phenylsuccinimide
- Epimid
- Fenosuccimide
- Fensuccimide [DCIT]
- Fensuximida [INN-Spanish]
- Lifene
- Methylphenylsuccinimide
- Milontin
- Milontin (TN)
- Milonton
- Mirontin
- Mirotin;7 Phenosuccimide
- N-Methyl-2-phenylsuccinimide
- N-Methyl-alpha-phenolsuccinimide
- N-Methyl-alpha-phenylsuccinimide
- Phensuximid
- Phensuximide (USP)
- Phensuximide [BAN:INN]
- Phensuximidum [INN-Latin]
- Phenylsuximide
- Succinimide, N-methyl-2-phenyl-
- Succitimal
Succinimide, N-methyl-2-phenyl- Brand Names Mixture
- No information avaliable
Succinimide, N-methyl-2-phenyl- Chemical_Formula
C11H11NO2
Succinimide, N-methyl-2-phenyl- RX_link
No information avaliable
Succinimide, N-methyl-2-phenyl- fda sheet
Succinimide, N-methyl-2-phenyl- msds (material safety sheet)
Succinimide, N-methyl-2-phenyl- Synthesis Reference
No information avaliable
Succinimide, N-methyl-2-phenyl- Molecular Weight
189.211 g/mol
Succinimide, N-methyl-2-phenyl- Melting Point
72 oC
Succinimide, N-methyl-2-phenyl- H2O Solubility
7020 mg/L
Succinimide, N-methyl-2-phenyl- State
Solid
Succinimide, N-methyl-2-phenyl- LogP
1.079
Succinimide, N-methyl-2-phenyl- Dosage Forms
Capsules
Succinimide, N-methyl-2-phenyl- Indication
For the treatment of epilepsy
Succinimide, N-methyl-2-phenyl- Pharmacology
Phensuximide suppresses the paroxysmal three cycle per second spike and wave EEG pattern associated with lapses of consciousness in absence (petit mal) seizures. The frequency of attacks is reduced by depression of nerve transmission in the motor cortex.
Succinimide, N-methyl-2-phenyl- Absorption
Rapid and complete
Succinimide, N-methyl-2-phenyl- side effects and Toxicity
No information avaliable
Succinimide, N-methyl-2-phenyl- Patient Information
No information avaliable
Succinimide, N-methyl-2-phenyl- Organisms Affected
Humans and other mammals
